according one source glaxosmithkline soon following pfizer lead significantly lopping chunk sales force past year company company admitted roi multiplexed sales calls multiple calls practice eroded company company quietly reacted erosion measured targeted reductions number calls per physician everyone waiting one company pfizer particular come publicly admit changing sales practices fast enough protect profit growth company wanted first blink unilateral move viewed risky pfizer blinked mean others follow i suspect execs seriously consider using pfizer move try gain competitive sales edge majors likely instead use move opportunity glaxosmithkline nyse gsk news made numerous overtures regard search blog read likely next followed many others pharma new world new world pharma i hope two enjoy productive relationship source news topic downsizing pharmaceutical sales forces head wonderful world pharmagossip